This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Aetna Appoints Michael Kolodziej, M.D., To Lead Oncology Strategies

Aetna (NYSE: AET) announced today that Michael Kolodziej, M.D., joined the company in January as national medical director for Oncology Strategies. He leads the strategic development, design and implementation of Aetna’s cancer care programs.

“We’re thrilled to welcome Dr. Kolodziej to Aetna. His extensive research experience and leadership in the field will help us continue to improve cancer care. Through collaboration with the medical and information technology communities, he will help create integrated, clinically advanced oncology programs that are safer, more effective and more affordable for our members,” said Ira Klein, M.D., Aetna’s chief of staff to the chief medical officer.

Kolodziej comes to Aetna from US Oncology where he served as medical director for oncology services and was chairman of the US Oncology Pharmacy and Therapeutics committee. He specializes in hematology and medical oncology and is board certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine. Kolodziej was a medical oncologist with New York Oncology Hematology, Albany Cancer Center.

After receiving his Bachelor of Arts degree from Washington University in St. Louis, MO and his medical degree from Washington University School of Medicine, Kolodziej completed his internship at Barnes Hospital at Washington University in 1985. He completed residencies in internal medicine and hematology-oncology at the Hospital of the University of Pennsylvania in 1987, and his fellowship in the Hematology-Oncology Section of the Hospital of the University of Pennsylvania in 1991. He has been published in more than 50 medical journal articles, abstracts and book chapters.

About Aetna

Aetna is one of the nation's leading diversified health care benefits companies, serving approximately 37.3 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities, Medicaid health care management services and health information technology services. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs